Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hAECs for Nonunion of Limb Fracture
NCT03031509Phase 2Unknown
- Sponsor
- Shanghai East Hospital
- Start
- Dec 2017
- Primary completion
- Mar 2018
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
Phase 2, randomised trial of human amniotic epithelial stem cells in bone fracture (2 arms), sponsored by Shanghai East Hospital. Primary endpoint: Time for bone union at 6 months. Status: unknown.
02
Drugs
human amniotic epithelial stem cells
03
Conditions
bone fracture
Beyond the preview
Go deeper on NCT03031509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03031509.